Abstract：Objective To explore the construction and application effect of anesthetic and psychopharmaceutical service system in general hospitals. Methods According to the management principles of anesthetic and psychotropic drugs in China, combined with the actual situation of the Department of Pharmacy, Subei People’s Hospital of Jiangsu Province, the anesthetic and psychotropic service system was constructed, the anesthetic and psychotropic drug prescriptions of 116 patients who were prescribed within one year before (September 1, 2018 to September 1, 2019) the construction were selected and recorded as pre-implementation, and the anesthetic and psychotropic drug prescriptions of 124 patients who were prescribed within one year after (January 1, 2020 to January 1, 2021) the construction were selected and recorded as the post-implementation. The standardization of distribution and storage of narcotic psychotropic drugs before and after implementation, drug prescription turnover time, and the incidence of drug prescription related problems during treatment were compared. Results After the implementation, the scores of the distribution and custody practices of narcotic psychotropic drugs were higher than those before the implementation (P ＜ 0.01). The quarter turnaround time and average turnaround time of narcotic psychotropic drugs prescription after implementation were shorter than before implementation (P ＜ 0.01). The total incidence of problems related to narcotic and psychotropic drugs prescription after the implementation was lower than before the implementation (P ＜ 0.01). Conclusion The anesthetic and pharmaceutical psychotropic service system realizes systematic and information-based management, effectively improves the standardization and management efficiency of the distribution and storage of anesthetic psychotropic drugs, and make patients’ medication more reasonable.
吉宁 潘俊 徐慧▲. 综合性医院麻醉精神药品药学服务体系的构建效果[J]. 中国医药导报, 2022, 19(5): 175-178.
JI Ning PAN Jun XU Hui▲. Effect of constructing anesthetic and psychopharmaceutical service system in general hospitals#br#. 中国医药导报, 2022, 19(5): 175-178.
[1] Vladimirov VY，Kovalev AV，Minaeva PV，et al. Overdose deaths from narcotic drugs and psychotropic substances in Russia （an analysis of materials for the period 2003 to 2018）[J]. Sud Med Ekspert，2019，62（5）：4-8.
[2] Rizvanova LN，Appolonova SA，Savchuk SA，et al. Comparison of sample preparation techniques in chemical-toxicological analysis of urine for the presence of narcotic drugs，psychotropic substances and their metabolites [J]. Sud Med Ekspert，2019，62（4）：42-46.
[3] Singh Balhara YP，Singh S. Provisions for Health Sector Response to Substance Use Disorders in the Indian Policy： A Critique of the National Policy on Narcotic Drugs and Psychotropic Substances [J]. J Psychoactive Drugs，2020，52（1）：93-100.
[4] Di Luca NM，Busardò FP，Pirani F，et al. Evolution of Italian laws banning trafficking，use and abuse of psychotropic drugs [J]. Ann Ist Super Sanita，2020，56（1）：76-89.
[5] Greenblatt DJ. Public Health Risk of Designer Psychotropic Drugs： Should PHASE Be Phased In [J]. Clin Pharmacol Ther，2019，106（6）：1175-1176.
[6] 卫生部.麻醉药品和精神药品管理条例[J].中国农村医学杂志，2006，4（1）：3-11.
[7] 卫生部.关于印发《精神药品临床应用指导原则》的通知[J].中华人民共和国卫生部公报，2007（4）：35-59.
[8] 樊莹莹，齐莹莹，穆星佳，等.我国麻醉药品和精神药品行政监管法规完善建议[J].中国药物警戒，2018，15（1）：28-31.
[9] 康怡，杨婧，张东肃，等.门诊麻醉药品和第一类精神药品处方的使用分析[J].中国临床药理学杂志，2020，36（19）：3140-3142，3147.
[10] Szigethy E，Knisely M，Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain [J]. Nat Rev Gastroenterol Hepatol，2018，15（3）：168-180.
[11] 高强.处方管理办法:中华人民共和国卫生部令，第53号[J].中国农村医学杂志，2007，5（3）：3-7.
[12] 胡碧霞.三部门发布公告5月1日起对芬太尼类物质实施整类列管[J].中国药物依赖性杂志，2019，28（2）：112.
[13] 赵志强.PDCA循环法干预病区麻醉药品和第一类精神药品的管理[J].中国药物与临床，2020，20（6）：991-993.
[14] 沈国荣，王永，张倢，等.我院中心药房麻精药品智能化管理系统的开发与应用[J].中国药房，2018，29（9）：11-14.
[15] Mitchell C，Dolan N，Dürsteler KM. Management of dependent use of illicit opioids [J]. BMJ，2020，368（6）：710-718.
[16] de Matos MB，de Mola CL，Trettim JP，et al. Psychoactive substance abuse and dependence and its association with anxiety disorders： a population-based study of young adults in Brazil [J]. Braz J Psychiatry，2018，40（4）：349-353.
[17] Kaye AD，Kandregula S，Kosty J，et al. Chronic pain and substance abuse disorders：Preoperative assessment and optimization strategies [J]. Best Pract Res Clin Anaesthesiol，2020，34（2）：255-267.
[18] 王成岗，黄元，吴世福，等.我国医务人员药物滥用监测认知调查[J].中国药物警戒，2020，17（10）：697-702， 706.
[19] 康怡，杨婧，张东肃，等.门诊麻醉药品和第一类精神药品处方的使用分析[J].中国临床药理学杂志，2020，36（19）：3140-3142，3147.
[20] 陈春玲，张晅，许建国，等.我院住院药房麻醉药品，第一类精神药品空安瓿，废贴回收的现状分析和改善[J].中国医药导报，2017，14（2）：122-126.
[21] 朱琼芳，黄哲燕，许淼，等.优化流程联合细节管理在手术麻醉中心药品管理中的实践及效果[J].现代临床护理，2019，18（11）：68-73.
[22] 程璐，贾元威，周理想.医院麻醉类药品的应用情况与分析[J].中国医药，2019，14（4）：591-594.
[23] 赵方，周林光.某院麻醉药品处方应用现状及其合理性分析[J].中国当代医药，2021，28（19）：162-165.
[24] 帅乐军，罗晓辉，马星钢.医院麻醉药品信息化管理系统的应用效果与体会[J].中国卫生信息管理杂志，2019， 16（5）：618-622.
[25] Soni A，Gowthamarajan K，Radhakrishnan A. Personalized Medicine and Customized Drug Delivery Systems： The New Trend of Drug Delivery and Disease Management [J]. Int J Pharm Compd，2018，22（2）：108-121.
[26] 陈秀兰.几种干预措施对病房药房麻醉药品和精神药品处方管理的效果分析[J].中国药物与临床，2019，19（6）：993-994.
[27] 谢桂添.PDCA循环在药房麻精药品管理中的应用效果观察[J].中国医药科学，2019，9（13）：144-146，234.
京公网安备 11010502046598号